1. A Randomized Trial of Bictegravir or Dolutegravir with Emtricitabine and Tenofovir Alafenamide (F/TAF) Followed by Open Label Switch to Bictegravir/F/TAF Fixed Dose Combination. (4th October 2017) Authors: Sax, Paul E; Dejesus, Edwin; Crofoot, Gordon; Ward, Douglas; Benson, Paul; Wei, Lilian; White, Kirsten; Collins, Sean; Martin, Hal; Cheng, Andrew; Quirk, Erin Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial. Issue 4 (April 2017) Authors: Sax, Paul E; DeJesus, Edwin; Crofoot, Gordon; Ward, Douglas; Benson, Paul; Dretler, Robin; Mills, Anthony; Brinson, Cynthia; Peloquin, Julie; Wei, Xuelian; White, Kirsten; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Lancet Issue: Volume 4:Issue 4(2017) Page Start: e154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults. (1st November 2016) Authors: Gallant, Joel; Brunetta, Jason; Crofoot, Gordon; Benson, Paul; Mills, Anthony; Brinson, Cynthia; Oka, Shinichi; Cheng, Andrew; Garner, Will; Fordyce, Marshall; Das, Moupali; McCallister, Scott Journal: Journal of acquired immune deficiency syndromes Issue: Volume 73:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide. (31st July 2018) Authors: Sax, Paul E.; DeJesus, Edwin; Crofoot, Gordon; Ward, Douglas; Benson, Paul; Dretler, Robin; Mills, Anthony; Brinson, Cynthia; Wei, Xuelian; Collins, Sean E.; Cheng, Andrew Journal: AIDS Issue: Volume 32:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study. (27th December 2019) Authors: Huhn, Gregory D; Crofoot, Gordon; Ramgopal, Moti; Gathe, Joseph; Bolan, Robert; Luo, Donghan; Simonson, Richard Bruce; Nettles, Richard E; Benson, Carmela; Dunn, Keith Journal: Clinical infectious diseases Issue: Volume 71:Number 12(2020) Page Start: 3110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. Issue 7 (July 2018) Authors: Daar, Eric S; DeJesus, Edwin; Ruane, Peter; Crofoot, Gordon; Oguchi, Godson; Creticos, Catherine; Rockstroh, Jürgen K; Molina, Jean-Michel; Koenig, Ellen; Liu, Ya-Pei; Custodio, Joseph; Andreatta, Kristen; Graham, Hiba; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Lancet Issue: Volume 5:Issue 7(2018) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. Issue 1 (January 2023) Authors: Gupta, Samir K; Berhe, Mezgebe; Crofoot, Gordon; Benson, Paul; Ramgopal, Moti; Sims, James; McDonald, Cheryl; Ruane, Peter; Sanchez, William E; Scribner, Anita; Liu, Shan-Yu; VanderVeen, Laurie A; Dvory-Sobol, Hadas; Rhee, Martin S; Baeten, Jared M; Koenig, Ellen Journal: Lancet Issue: Volume 10:Issue 1(2023) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason... Journal: Lancet Issue: Volume 8:Issue 7(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P100 Tenofovir alafenamide (TAF) in a single tablet regimen in initial HIV-1 therapy. (18th May 2015) Authors: Pozniak, Anton; Wohl, David; Thompson, Melanie; DeJesus, Edwin; Podzamczer, Daniel; Molina, Jean Michel; Crofoot, Gordon; Callebaut, Christian; Martin, Hal; McCallister, Scott Journal: Sexually transmitted infections Issue: Volume 91(2015)Supplement 1 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results. (4th October 2017) Authors: Daar, Eric; DeJesus, Edwin; Ruane, Peter; Crofoot, Gordon; Oguchi, Godson; Creticos, Catherine; Rockstroh, Jurgen K; Molina, Jean-Michel; Koenig, Ellen; Liu, Ya-Pei; Andreatta, Kristen; Graham, Hiba; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗